2019 ISHLT ( International Society of Heart Lung Transplantation ) 39Th Annual Meeting & Scientific Sessions

• – 07 RESEARCH SESSION 06 Pediatric Donor Utilization, MCS, Readmissions and More
• – 08 SYMPOSIUM SESSION 07 Making Co-Morbidities Great Again Practical Updates in Co-Morbidity Management
• – 09 RESEARCH SESSION 08 ISHLT Spotlight Heart Transplantation in Latin America
• – 10 SYMPOSIUM SESSION 09 Re-Focusing the Blurry Vision Biomarkers of Thoracic Allograft Rejection
• – 11 RESEARCH SESSION 10 Heart Donor Management and Allocation Setting It Up For Success
• – 12 RESEARCH SESSION 11 Chronic Lung Allograft Dysfunction Overcoming the Hurdle
• – 13 RESEARCH SESSION 12 When Short-Term Becomes Long-Term Transition from Temporary to Permanent Mechanical Support
• – 14 SYMPOSIUM SESSION 13 They Tell Me I Am Irregular Why Do They Care Arrhythmias in LVAD Recipients
• – 15 SYMPOSIUM SESSION 14 Part of (Their) World Discharging Patients Home with a New Device
• – 16 RESEARCH SESSION 15 Pharmacotherapy in Transplantation Reading the Tea Leaves to Improve Outcomes
• – 17 RESEARCH SESSION 16 Junior Faculty and Trainees Clinical Case Dilemmas The Best of the Best
• – 18 RESEARCH SESSION 17 Tolerance Is All We Need in Thoracic Transplantation
• – 19 RESEARCH SESSION 18 Ex-Vivo Heart Perfusion and Preservation Some Like It Hot – or Not!
• – 20 SYMPOSIUM SESSION 19 Chronic Lung Allograft Dysfunction (CLAD) The End of the Beginning
• – 21 RESEARCH SESSION 20 The Beat Goes On Arrhythmias and Pacing During MCS
• – 22 SYMPOSIUM SESSION 21 Short Term Mechanical Support Taking the Next Leap Forward
• – 23 SYMPOSIUM SESSION 22 What Do We Do Burning Platforms in Pediatric Thoracic Transplant
• – 24 SUNRISE SYMPOSIUM 01 In the Thick of It Hypertrophic and Amyloid Cardiomyopathies
• – 25 SUNRISE SYMPOSIUM 02 Immunobiology of the Older Lung Transplant Recipient
• – 26 SUNRISE SYMPOSIUM 03 From Isolated to Mainstream Evolving ECMO Strategies That Are Reshaping Outcomes
• – 27 SUNRISE SYMPOSIUM 04 Nobody is CLAD to See AMR in Lung Transplantation
• – 28 SUNRISE SYMPOSIUM 05 I Want to Ride My Bicycle Cardiopulmonary Exercise Testing (CPET) for PAH and CTEPH
• – 29 SUNRISE SYMPOSIUM 06 Making Deals with the Devil Substances of Abuse from Pre- to Post-Transplant
• – 30 SYMPOSIUM SESSION 27 Medical Management of LVAD Patients Once the Chest is Closed, the Trouble Begins
• – 31 RESEARCH SESSION 24 Molecular Diagnostics in Heart Transplantation It_s All in the Genes
• – 32 RESEARCH SESSION 29 Pediatric Lung Transplantation Are We Moving Forward
• – 33 RESEARCH SESSION 23 Hepatitis C+ Cardiac Donors Do They Get an A+
• – 34 SYMPOSIUM SESSION 25 The Magic Kingdom of the Bronchoscopy Pathogens with Real Implications and Those to Disregard
• – 35 RESEARCH SESSION 26 Mechanical Lung Support for Isolated Organs and Patients
• – 36 RESEARCH SESSION 28 Tissue is Not the Only Issue Advances in Thoracic Transplant Pathology
• – 37 RESEARCH SESSION 31 Slaying the Dragon Hepatitis C and Thoracic Transplantation
• – 38 RESEARCH SESSION 30 Get Up and Go! Predicting Survival in Heart Failure
• – 39 SYMPOSIUM SESSION 32 Ex-Vivo Lung Perfusion (EVLP) in 2019 From Research to Implementation
• – 40 RESEARCH SESSION 33 Brain Attack Strokes and MCS
• – 41 RESEARCH SESSION 34 Never Mind the Leaks Addressing Valvular Disease with LVADs
• – 42 SYMPOSIUM SESSION 35 Bring Out Your Dead The Postmortem Evaluation in the Thoracic Transplant Setting
• – 43 SYMPOSIUM SESSION 36 Learning from the Children Important Lessons from the Pediatric and Congenital Heart Disease VAD Experience
• – 44 SYMPOSIUM SESSION 37 JHLT at ISHLT The Year in a Capsule
• – 45 RESEARCH SESSION 38 Early Career Scientist Award Candidate Presentations
• – 46 RESEARCH SESSION 39 Walking a Tightrope The Double-Edged Sword of Drugs after Heart Transplant
• – 47 RESEARCH SESSION 41 Perfecting the Graft LVAD Pump Management, Outcomes and Medications
• – 48 RESEARCH SESSION 42 Too Much or Two Little Obesity and Frailty in MCS
• – 49 SYMPOSIUM SESSION 43 Changes in the World of Pulmonary Hypertension Nice or Not Nice
• – 50 RESEARCH SESSION 44 Philip K. Caves Award Candidate Presentations
• – 51 SYMPOSIUM SESSION 48 Advances in Short- and Long-Term Mechanical Circulatory Support – What’s Next
• – 52 RESEARCH SESSION 45 Acute Cardiac Rejection New Approaches to an Old Problem
• – 53 SYMPOSIUM SESSION 46 FUN and Games with FUNgal Infections in Lung Transplantation
• – 54 RESEARCH SESSION 47 Back to the Basics Physiological Alterations During Continuous Flow VAD Support
• – 55 RESEARCH SESSION 49 The Personal Connection Psychological Issues and Care for Donor Families, Patients and Providers
• – 56 RESEARCH SESSION 50 Pulmonary Hypertension in Translation From Novel Biomarkers to Cutting Edge Clinical Results
• – 57 SUNRISE SYMPOSIUM 07 Highways to Hell Chronic Lung Allograft Dysfunction
• – 58 SUNRISE SYMPOSIUM 08 Print, Replace or Innovate Alternative Strategies to Cardiac Transplantation
• – 59 SUNRISE SYMPOSIUM 09 MCS Infections New Twists in an Old Saga
• – 60 SUNRISE SYMPOSIUM 10 Cardiac Reverse Remodeling in MCS State of the Art
• – 61 SUNRISE SYMPOSIUM 11 The Mission IS Possible If You Choose to Accept it The Processes of Performing Research
• – 62 SUNRISE SYMPOSIUM 12 A Bloody Mess Management of Hematologic Complications in Transplantation and MCS
• – 63 PLENARY SESSION FRIDAY
• – 64 JOINT ISHLTIPTA SYMPOSIUM SESSION 56 EBV and CMV are Not as Easy as 1-2-3 When Caring for Pediatric Thoracic Transplant Recipients
• – 65 RESEARCH SESSION 51 Cardiac Allograft Vasculopathy A Never-ending Story
• – 66 JOINT ISHLTSCMR SYMPOSIUM SESSION 52 Cardiac MRI and the World of Heart Failure When Two Disciplines Harmonize
• – 67 RESEARCH SESSION 53 Chasing the Golden Snitch Optimizing Outcomes of MCS Infections
• – 68 RESEARCH SESSION 54 Swipe Right or Swipe Left Matching Donors and Recipients in Lung Transplantation
• – 69 RESEARCH SESSION 55 Score Now – Or Forever Hold Your Peace Prediction and Risk in MCS
• – 70 SYMPOSIUM SESSION 57 Take These Broken Lungs and Learn to Fly Great Debates for Patients with PAH Awaiting Transplant
• – 71 SYMPOSIUM SESSION 58 Resilience in the Face of Calamity The Art of Preventing PTE Disasters
• – 72 RESEARCH SESSION 59 Heart Transplant Short-Term Outcomes Getting it Right From the Start
• – 73 JOINT ISHLTABTO SYMPOSIUM SESSION 60 Combining Experiences to Enhance Thoracic Organ Transplantation Worldwide
• – 74 SYMPOSIUM SESSION 61 Making Them Count Enhancing Lung Donor Utilization
• – 75 RESEARCH SESSION 62 Under New Management Novel Strategies for MCS
• – 76 JOINT ISHLTICCAC SYMPOSIUM SESSION 63 Faster, Higher, Stronger Monitoring Exercise in Cyberspace
• – 77 RESEARCH SESSION 64 Highlights of Challenging Topics in Pediatric Heart Transplant and MCS
• – 78 SYMPOSIUM SESSION 65 All Talk, No Action New Strategies and Best Practices to Maximize Donor Heart Utilization
• – 79 RESEARCH SESSION 66 Between the Devil and the Deep Blue Sea Fungus or CMV
• – 80 RESEARCH SESSION 67 Diagnostics and Immunosuppression in Lung Transplantation
• – 81 RESEARCH SESSION 68 LV Recovery after MCS From Promise to Reality
• – 82 RESEARCH SESSION 69 Tricks of the Trade Management Considerations with Continuous Flow LVADs
• – 83 SYMPOSIUM SESSION 70 Matters of Life and Death Palliative and End of Life Care in Transplant Medicine
• – 84 SYMPOSIUM SESSION 71 Breaking Bad The Right Ventricle and Exercise Hemodynamics Rediscovered
• – 85 SUNRISE SYMPOSIUM 18 So Your Patient is on ECMO … Now What Considerations for Drug Dosing and Anticoagulation in ECMO
• – 86 SUNRISE SYMPOSIUM 17 A Brand-New Day The New Normal in Pediatric Thoracic Transplantation
• – 87 NRISE SYMPOSIUM 16 Fragility Not Necessarily Failure
• – 88 SUNRISE SYMPOSIUM 15 Lung Transplant Candidate Selection Challenging Cases
• – 89 SUNRISE SYMPOSIUM 13 A Fork in the Road How Can We Compare Interventional Therapies in CTEPH
• – 90 SUNRISE SYMPOSIUM 14 One Size Does Not Fit All Personalized Medicine in Heart Transplantation
• – 91 PLENARY SESSION SATURDAY
• – 92 RESEARCH SESSION 77 Thicker than Water Bleeding and LVADs
• – 93 SYMPOSIUM SESSION 76 Location, Location, and Allocation Worldwide Application of Broader Sharing in Lung Transplant
• – 94 SYMPOSIUM SESSION 75 Cardiac Allograft Vasculopathy Have Hope, Ye Who Enter
• – 95 RESEARCH SESSION 74 Frontiers of Cost-Efficacy and Policy in Transplant and MCS
• – 96 RESEARCH SESSION 73 Life on the Cutting Edge CTEPH and Surgical Management of PH
• – 97 SYMPOSIUM SESSION 72 Seeing the Light Antibodies in Thoracic Transplantation
• – 98 RESEARCH SESSION 80 Heart Transplant Long-Term Outcomes In It for the Long Haul
• – 99 RESEARCH SESSION 79 Go with the Flow Hemodynamic Guiding Therapies in Heart Failure
• – 100 RESEARCH SESSION 78 The Beginning of the End in Lung Transplantation PGD, AMR and CLAD
• – 101 RESEARCH SESSION 83 What_s Holding Me Back Exercise in LVAD Patients
• – 102 RESEARCH SESSION 82 Donor Lung Management Can We Do Better
• – 103 RESEARCH SESSION 81 Primary Graft Dysfunction and Acute Lung Rejection
• – 104 Q&A

104 Videos

Date of Release : April 3-6 2019